T1	Pharmacological_substance 27 37	bortezomib
N1000 	Reference T1 MeSH:D000069286	bortezomib
T2	Pharmacological_substance 38 50	lenalidomide
N1001 	Reference T2 MeSH:C467567	lenalidomide
T3	Pharmacological_substance 52 65	dexamethasone
N1002 	Reference T3 MeSH:D003907	dexamethasone
T4	Pharmacological_substance 73 83	bortezomib
N1003 	Reference T4 MeSH:D000069286	bortezomib
T5	Pharmacological_substance 84 97	dexamethasone
N1004 	Reference T5 MeSH:D003907	dexamethasone
T6	Pharmacological_substance 106 119	dexamethasone
N1005 	Reference T6 MeSH:D003907	dexamethasone
T7	Disorder 161 177	multiple myeloma
N1 	Reference T7 UMLS:C0026764	multiple myeloma
T8	Disorder 320 336	multiple myeloma
N2 	Reference T8 UMLS:C0026764	multiple myeloma
T9	Pharmacological_substance 457 467	bortezomib
N1006 	Reference T9 MeSH:D000069286	bortezomib
T10	Pharmacological_substance 503 514	thalidomide
N1007 	Reference T10 MeSH:D013792	thalidomide
T11	Pharmacological_substance 519 531	lenalidomide
N1008 	Reference T11 MeSH:C467567	lenalidomide
T12	Pharmacological_substance 788 798	bortezomib
N1009 	Reference T12 MeSH:D000069286	bortezomib
T13	Pharmacological_substance 803 816	dexamethasone
N1010 	Reference T13 MeSH:D003907	dexamethasone
T14	Pharmacological_substance 833 845	lenalidomide
N1011 	Reference T14 MeSH:C467567	lenalidomide
T15	Pharmacological_substance 941 954	dexamethasone
N1012 	Reference T15 MeSH:D003907	dexamethasone
T16	Pharmacological_substance 997 1007	bortezomib
N1013 	Reference T16 MeSH:D000069286	bortezomib
T17	Pharmacological_substance 1101 1112	thalidomide
N1014 	Reference T17 MeSH:D013792	thalidomide
T18	Pharmacological_substance 1116 1128	lenalidomide
N1015 	Reference T18 MeSH:C467567	lenalidomide
T19	Pharmacological_substance 1173 1193	proteasome inhibitor
N1016 	Reference T19 MeSH:D061988	proteasome inhibitor
T20	Pharmacological_substance 1219 1239	proteasome inhibitor
N1017 	Reference T20 MeSH:D061988	proteasome inhibitor
T21	Disorder 1665 1672	myeloma
N3 	Reference T21 UMLS:C0026764	myeloma
T22	Subject 147 155	patients
T23	Subject 306 314	patients
T24	Pharmacological_substance 427 448	proteasome inhibitors
N1018 	Reference T24 MeSH:D061988	proteasome inhibitors
T25	Pharmacological_substance 472 494	immunomodulatory drugs
N1019 	Reference T25 MeSH:D007155	immunomodulatory drugs
T26	Pharmacological_substance 818 820	VD
N1020 	Reference T26 MeSH:D014751	VD
T27	Pharmacological_substance 826 827	D
N1021 	Reference T27 MeSH:C026410	D
N1022 	Reference T27 MeSH:D001224	D
T29	Combination 0 13	Consolidation
T30	Combination 799 802	and
T31	Combination 828 832	plus
T32	Pharmacological_substance 847 850	VRD
T33	Subject 1024 1066	most patients entering this clinical trial
T37	Subject 1024 1066	most patients entering this clinical trial
T39	Subject 1024 1066	most patients entering this clinical trial
T40	Subject 1651 1659	patients
T42	Pharmacological_substance 1478 1487	alkylator
N1023 	Reference T42 MeSH:D000477	alkylator
